信达证券给予联影医疗“买入”评级：海外收入增长超40%，内生增长动能强劲

Group 1 - The core viewpoint of the article highlights that Xinda Securities has given a "Buy" rating to United Imaging Healthcare (688271.SH) based on significant overseas expansion and revenue growth exceeding 40% [1] - The report emphasizes a notable improvement in profitability, indicating strong internal growth momentum for the company [1] Group 2 - The article mentions that overseas orders have surged by 246%, covering over 50 countries and regions, which reflects the industry's explosive growth [1] - It warns of potential issues in the market, such as cutthroat competition, with some companies reportedly selling at a loss, which could lead to adverse effects in overseas markets [1]